Brieler H S, Thiede A
Zentralbl Chir. 1979;104(20):1337-44.
The therapeutic effect of TGLVP a new hormonogen of vasopression in demonstrated in a pilot study: 9 patients suffering from bleeding oesophageal varices (in total 16) could be sufficiently treated by TGLVP, as well as 9 patients (in total 13) with abdominal haemorrhage of unknown aetiology and localization. Good results can be expected by TGLVP to bring gastrointestinal bleedings to a standstill.
血管加压素一种新的激素原TGLVP的治疗效果在一项初步研究中得到证实：9例患有食管静脉曲张出血的患者（共16例）可通过TGLVP得到充分治疗，还有9例病因和部位不明的腹部出血患者（共13例）也可如此。预计TGLVP能有效止住胃肠道出血。
